Racial Disparity in Ductal Carcinoma in Situ: Risk-Predictive and Actionable Biomarkers for Early Intervention
Dana Franklin, Padmashree Rida, Nikita Jinna · 2026
Read Racial Disparity in Ductal Carcinoma in Situ: Risk-Predictive and Actionable Biomarkers for Early Intervention by Dana Franklin, Padmashree Rida, Nikita Jinna (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13255742.txt.
Description
Dana Franklin and co-authors wrote a 2026 review of racial disparities in ductal carcinoma in situ, an early breast lesion confined to the milk ducts. Many such lesions never turn invasive, yet some do, and doctors cannot reliably tell which. Black women face higher risks of progression, recurrence, aggressive disease, and death than other groups.
The review argues that progression is driven by interacting pathways, including genome instability, immune dysfunction, metabolic shifts, and Wnt signaling, all potentially shaped by social as well as biological forces. Candidate markers such as KIFC1 and ACKR1 may help flag dangerous lesions earlier. The authors call for risk tools that combine tumor biology, the surrounding tissue, and population context, so treatment intensity matches real risk and care becomes more equitable.
Catalog record
| CREATOR | Dana Franklin, Padmashree Rida, Nikita Jinna |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 107 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |